TY  - GEN
AU  - Wright,Thomas D
AU  - Raybuck,Christopher
AU  - Bhatt,Akshita
AU  - Monlish,Darlene
AU  - Chakrabarty,Suravi
AU  - Wendekier,Katy
AU  - Gartland,Nathan
AU  - Gupta,Mohit
AU  - Burow,Matthew E
AU  - Flaherty,Patrick T
AU  - Cavanaugh,Jane E
TI  - Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer
SN  - 1097-4644
PY  - 2021///0129
KW  - Apoptosis
KW  - drug effects
KW  - Benzodiazepinones
KW  - pharmacology
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Drug Synergism
KW  - Female
KW  - Humans
KW  - MAP Kinase Kinase 5
KW  - antagonists & inhibitors
KW  - Mitogen-Activated Protein Kinase 7
KW  - Phosphatidylinositol 3-Kinases
KW  - metabolism
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Piperazines
KW  - Proto-Oncogene Proteins c-akt
KW  - Pyridones
KW  - Pyrimidines
KW  - Pyrimidinones
KW  - Signal Transduction
KW  - Triple Negative Breast Neoplasms
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/jcb.29350
ER  -